| |
| |
|
| Insider
Information: |
Cahill Brian Joseph |
| Relationship: |
|
| City: |
Woodcliff Lake |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
47,958 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$227,801 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,958 |
|
|
| Total
Value |
$227,801 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eagle Pharmaceuticals, Inc. |
EGRX |
|
2024-02-27 |
47,958 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGRX |
Eagle Pharmaceuticals, In... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-02-27 |
4 |
D |
$6.44 |
$10,233 |
D/D |
(1,589) |
47,958 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
49,547 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-02-02 |
4 |
D |
$5.85 |
$5,464 |
D/D |
(934) |
45,747 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2024-01-05 |
4 |
D |
$5.13 |
$3,771 |
D/D |
(735) |
46,681 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2023-12-18 |
4 |
D |
$4.76 |
$2,152 |
D/D |
(452) |
47,416 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
47,868 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2023-02-28 |
4 |
D |
$28.00 |
$20,104 |
D/D |
(718) |
29,368 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2023-02-02 |
4 |
D |
$34.09 |
$26,761 |
D/D |
(785) |
30,086 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2023-01-30 |
4 |
D |
$33.21 |
$19,959 |
D/D |
(601) |
30,871 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2023-01-05 |
4 |
D |
$29.26 |
$21,477 |
D/D |
(734) |
31,472 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2022-12-19 |
4 |
D |
$30.03 |
$13,844 |
D/D |
(461) |
32,206 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
32,667 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2022-02-02 |
4 |
D |
$45.03 |
$36,249 |
D/D |
(805) |
24,667 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2022-01-31 |
4 |
D |
$45.94 |
$28,758 |
D/D |
(626) |
25,472 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2022-01-07 |
4 |
D |
$50.63 |
$13,316 |
D/D |
(263) |
26,098 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2022-01-05 |
4 |
D |
$50.69 |
$37,409 |
D/D |
(738) |
26,361 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2021-12-20 |
4 |
D |
$55.42 |
$25,881 |
D/D |
(467) |
27,099 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,900 |
27,566 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2021-01-29 |
4 |
D |
$46.67 |
$29,729 |
D/D |
(637) |
18,666 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2021-01-07 |
4 |
D |
$50.97 |
$12,080 |
D/D |
(237) |
14,303 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2021-01-05 |
4 |
D |
$50.02 |
$37,315 |
D/D |
(746) |
14,540 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
19,303 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial OfficerOfficer |
• – – |
2020-10-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,286 |
|
% |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
